Perindopril

Specifications

82834-16-0CAS Number

617-394-0EC Number

(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acidIUPAC Name

C19H32N2O5Chemical Formula

368.5 g/molMolecular Weight

PERINDOPRIL; 82834-16-0; Perindoprilum; McN-A-2833; S-9490; DTXSID6023440; Y5GMK36KGY; CHEBI:8024; DTXCID303440; S 9490; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid; (2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; (2S,3aS,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid; 1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))-; S9490; Pirindopril; (2S,3aS,7aS)-1-((2S)-2-(((2S)-1-ethoxy-1-oxopentan-2-yl)amino)propanoyl)-octahydro-1H-indole-2-carboxylic acid; (2S,3aS,7aS)-1-((2S)-2-(((2S)-1-ethoxy-1-oxopentan-2-yl)amino)propanoyl)octahydro-1H-indole-2-carboxylic acid; (2S,3aS,7aS)-1-[(S)-N-[(S)-1-Carboxybutyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; Erbumine, Perindopril; RefChem:57071; C09AA04; S 94903; S 9490 3; S 9490-3; 1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-; (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-((S)-2-(((S)-1-Ethoxy-1-oxopentan-2-yl)amino)propanoyl)octahydro-1H-indole-2-carboxylic acid; Prestarium; Coverex; Coversum; Coverene Cor; CAS-82834-16-0; Perindoprilum [Latin]; UNII-Y5GMK36KGY; Perindopril (USAN/INN); Perindopril [USAN:INN:BAN]; Perindopril Acid; McN-A 2833; NCGC00159509-02; SED-9490; MFCD00865859; DW-7950; BRN 4300272; Spectrum_001948; PERINDOPRIL [MI]; Spectrum2_001108; Spectrum3_001683; Spectrum4_000775; Spectrum5_001689; PERINDOPRIL [INN]; PERINDOPRIL [USAN]; PERINDOPRIL [VANDF]; CHEMBL1581; PERINDOPRIL [MART.]; SCHEMBL16205; BSPBio_003206; KBioGR_001190; KBioSS_002502; PERINDOPRIL [WHO-DD]; MLS002154153; BIDD:GT0786; SPBio_001216; GTPL6367; orb1705037; KBio2_002494; KBio2_005062; KBio2_007630; KBio3_002426; IPVQLZZIHOAWMC-QXKUPLGCSA-N; HMS2098M04; HMS2232M24; HMS3715M04; EX-A6377; HY-B0130; MSK10411; Tox21_113087; BDBM50248096; BDBM50493988; EBC-26815; AKOS025311315; Tox21_113087_1; CCG-221101; CS-1903; DB00790; FP26845; NCGC00274070-01; (2S)-2-[(1S)-1-Carbethoxybutylamino]-1-oxopropyl-(2S,3aS,7aS)-perhydroindole-2-carboxylic acid; (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonylbutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; ethyl N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvalinate; SMR001233453; SBI-0206736.P001; NS00117952; C07706; D03753; G78306; T21485; AB00918721_06; EN300-7481397; F980401; Q277785; S-90652; SR-01000841817; SR-01000841817-2; BRD-K92731339-227-02-3; BRD-K92731339-227-03-1; BRD-K92731339-227-04-9; (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic Acid; (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)butyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic Acid; (2s,3as,7as)-1-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-2-pent-yl]amino]propanoyl]-octahydro-1h-indole-2-carboxylic acid; (2S,3aS,7aS)-1-{(2S)-2-[(1S)-1-(ethoxycarbonyl)butylamino]propionyl}octahydro-1H-indole-2-carboxylic acid; [2S-[1[R*(R*)],2a,3a- b,7a-b]]-1-[2-[[1-(Ethoxycarbonyl) butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic Acid; 11H-Indole-2-carboxylic acid, octahydro-1-(2-((1-ethoxycarbonyl)butyl)amino)-1-oxopropyl)-, (2S-(1(R*(R*)),2-alpha,3a-beta,7a-beta))-; 1H-INDOLE-2-CARBOXYLIC ACID, 1-(2-((1-(ETHOXYCARBONYL)BUTYL)AMINO)-1-OXOPROPYL)OCTAHYDRO-, (2S-(1(R*(R*)),2.ALPHA.,3A.BETA.,7A.BETA.))-Synonyms